CHRD vs REGN · rev $5.25B vs P/E 14, rev $14.34B
Chord Energy Corp (CHRD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Chord Energy Corp (CHRD) is a oil & gas e&p company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CHRD revenue for 2024-12-31 was $5.25B. Net income was $848.6M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CHRD currently screens at market cap $7.15B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CHRD currently screens at market cap $7.15B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CHRD and REGN stock pages for the full models.
Not investment advice.